Literature DB >> 23980422

Synthesis of 3-farnesyl salicylic acid, a novel antimicrobial from Piper multiplinervium.

George A Kraus1, Divya Chaudhary, Sean Riley, Feng Liu, Allison Schlapkohl, Megan Weems, Gregory J Phillips.   

Abstract

Both 3-farnesyl salicylic acid and 3-geranyl salicylic acid were synthesized from 2,6-dibromophenol and showed low levels of antimicrobial activity against E. coli strains.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23980422      PMCID： PMC3891047     

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN： 1555-9475            Impact factor:   0.986


  7 in total

1.  Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin.

Authors:  U S Eggert; N Ruiz; B V Falcone; A A Branstrom; R C Goldman; T J Silhavy; D Kahne
Journal:  Science       Date:  2001-08-23       Impact factor: 47.728

2.  Mono- and disalicylic acid derivatives: PTP1B inhibitors as potential anti-obesity drugs.

Authors:  Suja Shrestha; Bharat Raj Bhattarai; Keun-Hyeung Lee; Hyeongjin Cho
Journal:  Bioorg Med Chem       Date:  2007-07-26       Impact factor: 3.641

3.  Trends in infectious disease mortality in the United States during the 20th century.

Authors:  G L Armstrong; L A Conn; R W Pinner
Journal:  JAMA       Date:  1999-01-06       Impact factor: 56.272

4.  3-Farnesyl-2-hydroxybenzoic acid is a new anti-Helicobacter pylori compound from Piper multiplinervium.

Authors:  T Rüegg; A I Calderón; E F Queiroz; P N Solís; A Marston; F Rivas; E Ortega-Barría; K Hostettmann; M P Gupta
Journal:  J Ethnopharmacol       Date:  2005-11-02       Impact factor: 4.360

Review 5.  Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.

Authors:  Judith N Steenbergen; Jeff Alder; Grace M Thorne; Francis P Tally
Journal:  J Antimicrob Chemother       Date:  2005-02-10       Impact factor: 5.790

6.  Antimicrobial and cytotoxic activity of agelasine and agelasimine analogs.

Authors:  Anders Vik; Erik Hedner; Colin Charnock; Linda W Tangen; Ørjan Samuelsen; Rolf Larsson; Lars Bohlin; Lise-Lotte Gundersen
Journal:  Bioorg Med Chem       Date:  2007-04-02       Impact factor: 3.641

7.  Design, synthesis and evaluation of aspirin analogues having an additional carboxylate substituent for antithrombotic activity.

Authors:  Ahmed Alagha; Edelmiro Moman; Mauro F A Adamo; Kevin B Nolan; Anthony J Chubb
Journal:  Bioorg Med Chem Lett       Date:  2009-06-13       Impact factor: 2.823
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.